Aragan

Aragan is a French company specializing in biomimetic dietary supplements, utilizing natural mechanisms for health solutions. The firm is known for its innovative product lines, catering to health-conscious consumers in the wellness sector. Founded in 2008 and headquartered in Paris, France, Aragan focuses on developing biomimetic supplements. The company was acquired by Ponroy Santé Group in September 2017, although financial terms were not disclosed.

The founder's specific history is not available, nor is any information on prior companies founded by them. Aragan specializes in biomimetic dietary supplements, with two primary product lines: PureProtect® and SynActifs®. PureProtect® delivers complete micronutrition solutions, emphasizing the integrity of active ingredients, while SynActifs® employs exclusive IPF technology to enhance bioavailability for sustained health benefits. The products are primarily distributed to pharmacies and health practitioners in France, with potential expansion into other European markets.

In 2020, Aragan generated a revenue of USD 29. 32 mn and achieved an EBITDA of USD 7. 12 mn. The company sells its biomimetic supplements through a B2B model, focusing on wholesale agreements with pharmacies to ensure a broad customer base.

Aragan has strategic plans to expand its product offerings, with upcoming launches designed to cater to emerging health trends. Additionally, the company aims to penetrate new markets across Europe by 2025. Recent funding from its acquisition by Ponroy Santé Group will support these initiatives, allowing Aragan to enhance its market presence and innovate within its product lines.